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ABSTRACT
Objectives: Uterine fibroids are one of the most common benign tumors of the female genital tract. The major complication 
of myomas in pregnancy is a recurrent pain, however the misscariage is the main threat. The negative impact of myomas 
on the course of pregnancy may also result in i.e. uterine bleeding, higher incidence of a maternal-fetal incommunicability, 
an incorrect position of the fetus and its deformities. 
Material and methods: The patient aged 31 was admitted to Mother and Child Health Center in Zabrze due to the 
threatened miscarriage. The primigravid at 19 weeks’ gestation was previously diagnosed with myoma. On admission 
the ultrasonography revealed one alive fetus in the uterus and a nodular change on the right side of the uterine fundus, 
13 x 11 cm in size and non-homogenous echo. 
Results: The patient was qualified to the conservative myomectomy. 11 days after the enucleation of 25 cm in diameter 
myoma, patient in good condition, with the maintained, alive foetus was discharged from the hospital. Patient at 34 weeks’ 
gestation was re-admitted due to the beginning of uterine contraction. After one week of observation within the ward, 
with tocolytic drugs and steroids administered, at 35th week of pregnancy the patient gave birth to a live daughter via 
the Ceasarian section. 
Conclusions: Prenatal myomectomy can be safely performed in the first and second trimester of pregnancy, however it is 
recommended to deliver the baby via Caesarean section, due to fear of intrauterine rupture of the uterus.
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INTRODUCTION
Uterine fibroids are benign tumors, of unknown aetiol-
ogy, arising from uterine smooth muscle cells. They are 
one of the most common benign tumors of the female 
genital tract, occurring in 20–50% of women in reproductive 
age [1]. The prevalence of uterine fibroids during pregnancy 
is underestimated. Due to late procreation, the prevalence 
of uterine fibroids in over 35-years-old women treated for 
infertility ranges from 12% to 25% [2].
The correlation of uterine fibroids with unfavorable perina-
tological results was unequivocally determined. The prospec-
tive studies, using ultrasound to monitor uterine fibroids during 
pregnancy, showed that the majority of myomas (60–78%) did 
not undergo any changes during pregnancy [3], however about 
1/3 of them may expand in the first trimester of pregnancy [2]. 
The negative impact of myomas on the course of preg-
nancy and on perinatological results has not been clearly 
defined. The main threat posed by the presence of myomas 
in early pregnancy is miscarriage. The incidence of sponta-
neous abortion is almost doubled taking pregnant women 
with uterine fibroids into consideration. The size of a single 
myoma does not affect the incidence of miscarriages, but 
numerous myomas may even triple the incidence of early 
pregnancy losses (23.6% and 8.0% respectively) [2]. 
Early miscarriage is more common among women with 
fibroids located in the uterine body compared to the lower 
part of the womb and in the case of intramural or submu-
cosal myomas.  It has been noticed that the presence of 
fibroids increases the uterine contractile activity. They may 
also cause a compression effect on the developing fetal 
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egg. The myomas are also responsible for disturbances in 
the blood supply to the placenta and fetus, as well as for 
the increased risk of uterine bleeding in early pregnancy [4].
The location of the fibroid determines the risk of bleed-
ing. Bleeding in early pregnancy is much more common in 
cases with sub mucous fibroids or insertion of the placenta 
near a fibroid and may have an adverse impact on fertility [5].
The situation becomes much more complicated in late 
pregnancy. According to literature data, the major compli-
cation is the syndrome of painful myomas of pregnancy. 
It occurs in second- and early third-trimester and is charac-
terized by pain and occasionally bleeding. 
Moreover, pregnant women with fibroids, in comparison 
to pregnant women without them, are more likely to have 
premature uterine contraction (16.1% and 8.7% respec-
tively) and premature delivery (16.0% and 10.8%). This is 
particularly true for cases where the fibroids contact the 
placenta [2].
Furthermore, fibroids are associated with a threefold 
increase of the risk of placental abruption. Confirmed risk 
factors for placental abruption are as follow: submucosal 
myomas, placental implantation in direct contact with uter-
ine myoma (58%, compared to 2.5% in other sites) and 
myomas with volume greater than 200 cm3 [6].
Another important aspect is the correlation between the 
presence of uterine fibroids and the placenta praevia. So far, 
this phenomenon has been evaluated only in two studies, 
which showed that uterine fibroids may double the risk of 
placenta praevia. This risk is comparable in patients after 
previous operations on the uterine myometrium (caesar-
ean section, myomectomy) [7].
In addition, the influence of uterine myomas on the oc-
currence of fetal anomalies has been proven. Although, they 
do not affect the growth of the fetus, their presence may 
be associated with a reduction of blood flow through the 
placenta and clinical IUGR exponents. Rarely, large myomas 
may deform the uterine cavity by causing compression, 
causing fetal deformities such as: dolichocephaly (due to 
lateral pressure on the skull of the fetus), torticollis (incor-
rect neck position in utero) and weakness of one of the 
limbs [4, 8].
It should also be remembered that the risk of abnormal 
fetal position in pregnant women with myomas increases 
and in relation to the group of women with unaltered uter-
us, it occurs in 13% and 4.5% of cases respectively. Large 
fibroids, numerous myomas, fibroids in the lower uterus 
and submucosal myomas are documented risk factors for 
abnormal fetal position.  Moreover, the presence of uterine 
fibroids is associated with an almost fourfold increased risk 
of pregnancy completion by caesarean section (respectively 
in 48.8% and 13.3%) compared to the control group, due to 
above mentioned factors [8].
MATERIAL AND METHODS
Patient aged 31 was admitted to Mother and Child Health 
Center in Zabrze on February 21, 2018 due to threatened 
miscarriage (ICD10: O20.0). The primigravid at 19 weeks’ ges-
tation was previously diagnosed with myoma. First day of last 
menstrual period: October 15, 2017. Due date: July 22, 2018. 
At admission ultrasonography was performed with following 
results: one alive fetus in the uterus, biparietal diameter (BPD) 
3.8 cm (corresponding 17w3d), head circumference (HC) 
15 cm (corresponding 18w0d), abdominal circumference (AC) 
12cm (corresponding 17w5d), femur length (FL) 2.5 cm (corre-
sponding 17w4d), average ultrasound age (AUA) 17w4d, fetal 
weight 208 g, anterior placenta with no abruption or hema-
toma. Correct amniotic fluid index (AFI) and fluid translucency, 
fetal heart rate (FHR) detected. In right site of uterine fundus, 
a nodular change, in size of 13 x 11 cm and non-homoge-
nous echo, was found (Fig. 1).  The structure was assessed as 
myoma. No deviations in laboratory urine test were found. 
The following abnormalities in laboratory blood tests were 
found: hemoglobin (HGB) — 11.8 g/dL (norm: 12.0–16.0 g/dL), 
C-reactive protein (CRP) 13.01 mg/dL (norm: < 5 mg/dL), 
D-Dimer 2018, 1 ngFEU/mL (norm: < 500 ngFEU/mL), fibrino-
gen 546 mg/dL (norm: 200–420 mg/dL). 
RESULTS
On February 22, 2018, after the above-mentioned 
examinations, the patient was qualified and subjected to 
the conservative myomectomy. After receiving patient’s 
consent, general anesthesia was conducted. After prepar-
ing the operating field, a midline incision of the abdomen 
(with navel omission) was performed. An enlarged, spherical 
uterus was revealed, with the dimensions corresponding to 
18 weeks of gestation. In the right site of uterine fundus the 
myoma with a diameter of 25 cm, reaching the rib arches 
was found, accompanied by two smaller myomas —  with 
diameter of 1 cm and 4 cm (Fig. 2).  Enucleation of uter-
ine fibroids was performed, next the sutures were put on 
Figure 1. Patient’s ultrasonography at hospital admission
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the remaining cavities (Fig. 3).  Four woundclot hemostatic 
gauzes were applicated on the remaining cavities. Next the 
hemostasis control was made. After the final inspection of 
the peritoneal cavity a drain was installed on the left side of 
the abdomen. Next the midline incision was closed. Patient 
in general good condition, with the maintained, alive foetus 
was transferred to the post-operative room. 
The ultrasonography performed on February 23, 
2018 raveled: one alive foetus in the uterus. FHR was de-
tected and assessed as 157/min. Placenta detected in uter-
ine fundus and on its anterior wall.  Above the uterus, on the 
left side, hematoma with dimensions 93 x 55 x 21 mm was 
found. A control ultrasound was ordered for the next day. 
On February 24, 2018 in the USG examination FHR 
was detected (FHR 144/min) as well as the foetus move-
ments. Amniotic fluid pocket — 32 mm. Kidneys on both 
side without obstruction. Intestinal loops widened No free 
fluids in the peritoneal cavity or in recto-uterine pouch. 
The next control ultrasound examination, on the Feb-
ruary 27, 2018 revealed one alive foetus in cephalic lon-
gitudinal lie with FHR 146/min. Anterior placenta with no 
abruption. Normal AFI. BPD 4.18 cm (corresponding: 18w4d), 
HC 15.12 cm (corresponding: 18w1d), AC 12.91 cm (cor-
responding 18w3d), FL 2.68 cm (corresponding: 18w1d). 
AUA 18w2d and the fetal weight 234 g. No features of car-
diovascular centralization were found. Flow in the umbilical 
cord PI 1.4. The little amount of free fluid in recto-uterine 
pouch (2.47 x 3.23 cm). 
After the operation, the laboratory blood tests were 
performed daily. The hemoglobin level (HGB) decreased 
until the 3rd day after surgery, with the lowest value 7.8 g/dL 
(norm: 12.0–16.0 g/dL), and then started to increase. 
On the March 5, 2018, the last control USG was performed, 
with following results: one alive foetus in cephalic longitu-
dinal lie with FHR 154/min. BPD 4.34 cm (corresponding: 
19w0d), HC 16.28 cm (corresponding: 19w0d), AC 14.26 cm 
(corresponding: 19w4d), FL 3.29 cm (corresponding: 20w2d). 
AUA 19w3d and the fetal weight 315 g. Flow in the umbilical 
cord PI 1.17. Flow in fetal middle cerebral artery PI 1.44. After 
above results the decision of discharge from the hospital was 
made. Patient was discharged in general good condition, 
with following recommendations: Tardyferon (Ferrosi sulfas) 
80 mg p.o 3 times a day., Luteina (Progesterone) 100 mg p.v. 
2 times a day, Laktuloza (Lactulose) 7.5 g/15 mL once a day. 
The post operation visit was scheduled after one week and 
during the examination patient did not report any pain or 
discomfort. The skin cuttings were healing correctly. 
On the March 29, 2018 patient at 23 weeks’ gestation was 
re-admitted to Mother and Child Health Center in Zabrze 
due to pain in lower abdomen. Pain was described as of the 
nature of renal colic. Laboratory blood tests taken at addmi-
tion revealed following deviations: elevated white blood 
cells number (WBC) — 11620/µl (norm: 4000–10200/µL) and 
lowered erytrocates number (RBC) — 2.38 mln/µL (norm: 
4.10–5.48 mln/µL), HGB 10.1 g/dL (norm: 12.0–16.0 mg/dL) 
and HTC 30.6 L% (norm: 35.0–47.0 L%). Urine specific grav-
ity was also changed: 1.030 (norm: 1.015–1.025). Cervical 
swab for bacterial culture and sensitivity test was taken, 
and the empiric therapy with Amoxicilin/Clavulanic Acid 
(Taromentin) acid was administered. 
Next the ultrasound was made with following results: 
one alive foetus, FHR detected. Anterior placenta with grade 
1 maturity. Normal AFI. BPD 5.5 cm (corresponding: 22w5d), 
HC 20.2 cm (corresponding: 22w2d), AC 18.0 cm (correspond-
ing 22w5d), FL 4.3 cm (corresponding: 24w0d). The estimated 
fetal weight 577 g. Kidneys on both side without obstruction.
The next day, on March 30, 2018 a surgical consultation 
took place. During the examination, the patient did not 
report any pain. The test result without deviations.
In the results bacterial culture of cervical swab, obtained 
after 5 days (on April 3, 2018), Streptococcus agalactiae was 
not cultured.
After above described diagnostic the patient underwent 
psychiatric consultation. The patient confessed to the doctor 
that she had been feeling well until the time she was hospital-
ized. In the past, she attended psychotherapy due to anxiety 
disorders. At the time of the examination she tolerated her 
Figure 2. Gravid uterus compression by the 25 cm diameter leiomyoma
Figure 3. Resected myomas
323
Anna Fuchs et al., Uterine fibroids in pregnancy
www. journals.viamedica.pl/ginekologia_polska
stay in the hospital badly, especially because of receiving 
contradictory information about her medical condition. the 
patient developed anxiety and sleep problems. Her husband’s 
company made her feel better. The psychiatrist diagnosed 
the patient with adaptive disorders (ICD10: F43.2) and anxi-
ety disorders in the anamnesis. The doctor recommended 
regular contact with a psychologist in the ward. In the event 
of deterioration in mental health, he recommended contact-
ing a psychiatrist. Also in the case of clear need, he ordered 
Diphergan (Phrometazinum) 10mg temporarily.
During the stay in the hospital, the patient’s health 
improved. The patient in a good general condition with 
recommendations for the use of magnesium, Tardyferon 
(Ferrosi sulfas), Luteina (Progesterone) and Lakcid (Lactoba-
cillus rhamnosus), was discharged from the ward, on March 
31, 2018 with the pregnancy maintained alive.
On the June 20, 2018 patient was admitted to Mother 
and Child Health Center in Zabrze on due to the begin-
ning of uterine contraction (ICD10: O60.0). The primigravid 
at 34 weeks’ gestation underwent an ultrasonography test 
with following results: one alive foetus in the uterus, in 
the longitudinal fetal lie. Biparietal diameter (BPD) 8.5 cm 
(corresponding 34w2d), head circumference (HC) 29.8 cm 
(corresponding 32w6d), abdominal cimcurference (AC) 
30.2 cm (corresponding 34w1d), femur length (FL) 6.55 cm 
(corresponding 33w5d), average ultrasound age (AUA) 3w4d, 
fetal weight +/- 2300 g, anterior placenta with no abruption or 
haematoma. Correct amniotic fluid index (AFI) and fluid trans-
lucency, fetal heart rate (FHR) detected. Preserved continuity 
of the anterior wall of uterine muscle. Flow in the umbilical 
cord PI -0.56. Flow in fetal middle cerebral artery PI -1.1.
It was decided to observe the patient within the ward 
and terminate pregnancy at week 35 via caesarian section. 
Tocolytic drugs and steroids were administered. 
In the 8th day of hospitalization (on the June 28) the 
Ceasarian section (ICD20: 82.0), from transverse cut was 
performed, at 35th week of pregnancy. The patient gave 
birth to a live daughter with Apgar 10/10. The girl’s weigh 
was 2510 g and her body’s length was 53 cm. The course 
of hospitalization was uncomplicated and patient was dis-
charged from the Mother and Child Health Center in Zabrze 
on the July 3. 
DISCUSSION
Contrary to popular opinion, diagnosis of uterine fi-
broids during pregnancy is not an easy issue. In physical 
examination, it is possible to diagnose 42% of large (> 5 cm) 
and 12.5% of smaller fibroids (3–5 cm) [8]. The usefulness of 
ultrasound examination in pregnancy is limited, mainly due 
to the difficulty in differentiating the physiological thicken-
ing of the uterine myometrium. During USG examination 
fibroids are only diagnosed in 1.4–2.7% of cases [9].
It may seem that conservative treatment, before preg-
nancy, is a much safer method of treatment of uterine 
fibroids, however it has been reported that prenatal my-
omectomy can be safely performed in the first and second 
trimester of pregnancy [10], and perinatological results in 
women subjected to this operation are comparable to those 
obtained in women treated conservatively [11].
Various studies reported a lower incidence of premature 
labor, premature rupture of membranes and preterm labor 
in a group of women who underwent elective myomectomy 
during pregnancy than in a group who received conserva-
tive treatment and a control group of pregnant women with 
no evidence of leiomyomas. The authors concluded that 
elective myomectomy during pregnancy as a preventative 
measure before the onset of acute complications is a safe 
option when done early in carefully selected patients [12].
The pregnancy of our patient was extremely high-risk 
with placental abruption. We confirmed following risk fac-
tors: submucosal myomas, placental implantation in direct 
contact with uterine myoma and the myoma with volume 
greater than 500 cm3. Myomas with size of 25 cm could 
also lead to abnormal fetal position, and subsequentaly to 
perinatal complications. 
We need to remember that myomas can distort the 
architecture of the uterus and interfere with myometrial 
contraction, leading to uterine atony and postpartum bleed-
ing. Also one of the studies showed that retained placenta 
is more common in all women with myomas compared to 
the control group, regardless of the location of the fibroid 
(1.4% and 0.6%, respectively) [8].
The patient met the criteria, qualifying her for the proce-
dure, i.e. lack of response to conservative treatment, severe 
pain due to degeneration of the submucosal or pedunculat-
ed myoma, fast growing myoma and large myoma (> 5 cm) 
located in the lower part of the uterus [12].
The decision to carry out myomectomy in 19th week of 
pregnancy allowed to avoid the above risks, and allowed 
fetus to develop. 
It is recommended to perform Caesarean section on wom-
en who underwent myomectomy during pregnancy, due to 
fear of intrauterine rupture of the uterus. This method of termi-
nating pregnancy was decided in the case of our patient [11].
There are other therapeutic options for uterine myo-
mas. If they do not threaten the development of pregnancy 
in a direct way, however, they make it difficult to deliver or 
may result in post-partum hysterectomy, it is possible to per-
form myomecotmy during caesarean section. Nowadays, it 
is believed that every effort should be made to avoid caesar-
ean section, taking  myomectomy case into consideration, 
due to a reasonable risk of severe haemorrhage requiring 
blood transfusion, uterine artery ligation and / or intra- and 
post-operative hysterectomy [13–15].
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Pedunculated myomas can be safely removed during 
caesarean section without increasing the risk of hemor-
rhage [16]. 
Bilateral uterine arterial embolization (UAE) is a method, 
that allows to control postpartum bleeding. UAE application 
immediately after cesarean section in women with uterine 
myomas can effectively reduce postpartum blood loss and 
minimize the risk of myomectomy or hysterectomy. but it 
is absolutely contraindicated in pregnant women and in 
women planning pregnancy in the future [17].
CONCLUSIONS
Uterine fibroids are one of the most common benign 
tumors of the female genital tract. The major complication 
of myomas in pregnancy is recurrent pain. It can usually 
be controlled by conservative treatment, however, in rare 
cases, fibroids may require surgical resection, as in our pa-
tient’s case [18].
In the majority cases of women with fibroids, pregnancy 
goes ahead without complications, however, according to lit-
erature data, in these cases were observed: increased frequen-
cy of spontaneous abortions and premature births, increased 
risk of bearing ablation, higher incidence of maternal-fetal 
incommunicability, incorrect position of the fetus, more of-
ten performed cesarean surgery, higher probability of post-
partum haemorrhage. Prenatal myomectomy can be safely 
performed in the first and second trimester of pregnancy, 
however it is recommended to deliver the baby via Caesar-
ean section, due to fear of intrauterine rupture of the uterus. 
UAE is an alternative procedure for surgical interven-
tion in the treatment of symptomatic uterine myomas, but 
it is absolutely contraindicated in pregnant women and in 
women planning pregnancy in the future
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